MD Anderson, Texas Children's Hospital

Texas Children's Hospital, MD Anderson join forces to fight childhood cancer
Texas Children’s Hospital and the University of Texas MD Anderson Cancer Center on Wednesday announced a partnership that will include the creation of a joint pediatric oncology program to fight childhood cancer.
Houston’s MD Anderson, Texas Children’s Hospital announce collaboration to combat childhood cancer
MD Anderson says the collaborative, set to begin in 2026, will combine the two institutions’ patient populations to “increase pediatric cancer clinical trials.”
UT MD Anderson Cancer Center, Texas Children’s Hospital launch partnership targeting childhood cancer
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital are forming a new partnership aimed at addressing childhood cancer.
Texas Children's Hospital and UT MD Anderson Announce Joint Venture to End Childhood Cancer
Texas Children's Hospital and The University of Texas MD Anderson Cancer Center have announced a transformational collaboration dedicated solely to pediatric cancer care. Approved by the Texas Children's Board of Trustees and the UT System Board of Regents,
MD Anderson, Texas Children's Hospital partner to end childhood cancer
University of Texas MD Anderson Cancer Center and Texas Children's Hospital, both based in Houston, have established a joint venture with the aim of ending childhood cancer. The partnership has been approved by the University of Texas Board of Regents and the Texas Children's Board of Trustees, according to a Feb. 19 news release from MD Anderson.
UT MD Anderson, Texas Children’s team up for pediatric cancer care
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital announced a joint venture dedicated to pediatric cancer care that is expected to launch in early 2026.
Texas Children's Hospital, MD Anderson Cancer Center to launch pediatric cancer joint venture
Texas Children’s Hospital and the University of Texas MD Anderson Cancer Center said Feb. 19 both of their boards of regents have signed off on a new joint venture to “end childhood cancer.” The partnership includes a joint pediatric oncology program,
Hosted on MSN1d
Banned Words at FDA; Top Cancer Center Halts DEI Initiatives; 'End Childhood Cancer'
"Woman," "elderly," and "disabled" were among a list of banned words reportedly circulating within the FDA, which the White ...
GEN2d
MD Anderson Receives Nearly $23 Million for Cancer Research and Faculty Recruitment
Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.
News Medical on MSN2d
CPRIT awards nearly $23 million to MD Anderson for cancer research projects
The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...
Targeted Oncology1d
Updated Findings on Datopotamab Deruxtecan in Urothelial Cancer Treatment
Bernstam, MD, discusses updated findings from the phase 1 TROPION-PanTumor01 study of datopotamab deruxtecan-dlnk in heavily ...
The Texas Tribune on MSN12d
Texas universities could face funding cuts for health care research under new Trump administration policy
A federal judge blocked a new National Institutes of Health policy from going into effect in 22 states that sued the agency, ...
EurekAlert!4d
MD Anderson receives nearly $23 million in CPRIT funding for cancer research, faculty recruitment
The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...
Bantam Pharmaceutical Announces Activation of First Phase 1 Clinical Trial Site at MD Anderson Cancer Center
Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...
Science Daily6d
Scientists find new biomarker that predicts cancer aggressiveness
Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.